Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00650182Phase 2Completed
A Phase 2 trial of fentanyl, naltrexone in chronic pain, sponsored by ALZA Corporation. Started Jan 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00650182.